ITRACONAZOLE
| Brand name | ONMEL |
|---|---|
| Active ingredient | ITRACONAZOLE |
| Strength | 200MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | April 2010 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 8486456 | October 2028 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.